1-5 of 5
Kechen Ban
Close
Sort by
Journal Articles

BCR-ABL1 mediates up-regulation of Fyn in chronic myelogenous leukemia

Brief Report
Kechen Ban, Yin Gao, Hesham M. Amin, Adrienne Howard, Claudia Miller, Quan Lin, Xiaohong Leng, Mark Munsell, Menashe Bar-Eli, Ralph B. Arlinghaus, Joya Chandra
Journal: Blood
Blood (2008) 111 (5): 2904–2908.
https://doi.org/10.1182/blood-2007-05-091769
Published: 2008
Journal Articles

NPI-0052, a novel proteasome inhibitor, induces caspase-8 and ROS-dependent apoptosis alone and in combination with HDAC inhibitors in leukemia cells

Claudia P. Miller, Kechen Ban, Melanie E. Dujka, David J. McConkey, Mark Munsell, Michael Palladino, Joya Chandra
Journal: Blood
Blood (2007) 110 (1): 267–277.
https://doi.org/10.1182/blood-2006-03-013128
Published: 2007
Journal Articles

Fyn Upregulation Is a Novel ROS-Dependent Mechanism Controlling CML Growth, Progression and Imatinib Resistance.

Joya Chandra, PhD, Hesham M. Amin, MD, Adrienne Howard, Claudia P. Miller, MS, Quan Lin, PhD, Kechen Ban, PhD
Journal: Blood
Blood (2006) 108 (11): 2241.
https://doi.org/10.1182/blood.V108.11.2241.2241
Published: 2006
Journal Articles

The Novel, Orally Active Proteasome Inhibitor, NPI-0052, Induces Apoptosis in Leukemia Lymphoma Cell Lines and Patient Specimens.

Claudia P. Miller, MS, Kechen Ban, PhD, Stacey L. Ruiz, Saskia Neuteboom, PhD, Michael Palladino, PhD, David McConkey, PhD, Joya Chandra, PhD
Journal: Blood
Blood (2005) 106 (11): 241.
https://doi.org/10.1182/blood.V106.11.241.241
Published: 2005
Journal Articles

Increased Superoxide Levels, HO-1 and Fyn Protein Expression in Bcr/abl Overexpressing Cells: Implications for Adaptation and Survival in an Oxidatively Challenging Environment.

Joya Chandra, PhD, Kechen Ban, PhD
Journal: Blood
Blood (2005) 106 (11): 4403.
https://doi.org/10.1182/blood.V106.11.4403.4403
Published: 2005